The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
seattle genetics | 1102 |
agensys | 82 |
spirogen | 48 |
medimmune | 36 |
bayer intellectual property | 25 |
bayer pharma | 23 |
genentech | 20 |
daiichi sankyo company ltd | 17 |
spirogen developments | 12 |
masterson, luke | 7 |
seattle genetics | 47 |
genentech | 3 |
medlmmune | 1 |
seattle genectics | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
monomethylvaline compounds capable of conjugation to ligands | 77 | 2003 |
antibody drug conjugates (adc) that bind to 191p4d12 proteins | 51 | 2010 |
novel binder-drug conjugates (adcs) and their use | 51 | 2011 |
humanized antibodies to liv-1 and use of same to treat cancer | 43 | 2010 |
drug conjugates and their use for treating cancer, an autoimmune disease or an infectiou… 🛈 | 36 | 2002 |
cd19 binding agents and uses thereof | 36 | 2007 |
cd33 antibodies and use of same to treat cancer | 31 | 2012 |
antibody drug conjugates (adc) that bind to 158p1d7 proteins | 31 | 2012 |
targeted pyrrolobenzodiazapine conjugates | 29 | 2010 |
methods of inhibition of protein fucosylation in vivo using fucose analogs | 29 | 2010 |